Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert? Implantation in Uveitic Eyes: A Retrospective Study

详细信息    查看全文

• 作者：Daniel B. Moore ; Sandra Stinnett ; Glenn J. Jaffe…
• 关键词：Uveitis ; Glaucoma ; Uveitic glaucoma ; Glaucoma drainage device ; Retisert ; Ahmed valve
• 刊名：Ophthalmology and Therapy
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：4
• 期：2
• 页码：103-113
• 全文大小：546 KB
• 参考文献：1.Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol. 1990;74:223-.PubMedCentral CrossRef PubMed
  2.Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13:96-.CrossRef PubMed
  3.Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13:461-.CrossRef PubMed
  4.Takahasi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46:556-2.CrossRef
  5.Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62-.CrossRef PubMed
  6.Ansari H, Kempen JH. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma. Am J Ophthalmol. 2010;149:699-00.CrossRef PubMed
  7.Landers J, Martin K, Sarkies N, et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119:694-02.CrossRef PubMed
  8.Jaffe GJ, Ben-Nun J, Guo H, et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107:2024-3.CrossRef PubMed
  9.Callanan DG, Jaffe GJ, Martin DF, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008;126:1191-01.CrossRef PubMed
  10.Pavesio C, Zierhut M, Bairi K, Fluocinolone Acetonide Study Group, et al. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology. 2010;117:567-5.CrossRef PubMed
  11.Campochiaro PA, Nguyen QD, Hafiz G, et al. Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants. Ophthalmology. 2013;120:583-.CrossRef PubMed
  12.Friedman DS, Holbrook JT, Ansari H, MUST Research Group, et al. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013;120:1571-.PubMedCentral CrossRef PubMed
  13.Araujo SV, Spaeth GL, Roth SM, Starita RJ. A 10-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology. 1995;102:1753-.CrossRef PubMed
  14.Yuki K, Shiba D, Kimura I, et al. Trabeculectomy with or without sub-Tenon injection of triamcinolone acetonide in treating secondary glaucoma. Am J Ophthalmol. 2009;147:1055-0.CrossRef PubMed
  15.Giangiacomo J, Dueker DK, Adelstein E. The effect of preoperative subconjunctival triamcinolone administration on glaucoma filtration. I. Trabeculectomy following subconjunctival triamcinolone. Arch Ophthalmol. 1986;104:838-1.CrossRef PubMed
  16.Tham CC, Li FC, Leung DY, et al. Intrableb triamcinolone acetonide injection after bleb-forming filtration surgery (trabeculectomy, phacotrabeculectomy, and trabeculectomy revision by needling): a pilot study. Eye. 2006;20:1484-.CrossRef PubMed
  17.Teixeira SH, Doi LM, Freitas Silva AL, et al. Silicone Ahmed glaucoma valve with and without intravitreal triamcinolone acetonide for neovascular glaucoma: randomized clinical trial. J Glaucoma. 2012;21:342-.CrossRef PubMed
  18.Koval MS, Moster MR, Freidl KB. Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial. Am J Ophthalmol. 2014;158:395-01.CrossRef PubMed
  19.Kempen JH, Altaweel MM, Holbrook JT, Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916-8.PubMedCentral CrossRef PubMed
  20.Malone PE, Herndon LW, Muir KW, Jaffe GJ. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am J Ophthalmol. 2010;149:800-.CrossRef PubMed
  21.Ahmad ZM, Hughes BA, Abrams GW, Mahmoud TH. Combined posterior chamber intraocular lens, vitrectomy, retisert and pars plana tube in noninfectious uveitis. Arch Ophthalmol. 2012;130:908-3.CrossRef PubMed
  22.Da Mata A, Burk S, Netland PA, et al. Management of uveitic glaucoma with the use of Ahmed valve. Ophthalmology. 1999;106:2168-2.CrossRef PubMed
  23.Ozdal PC, Vianna RNG, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye. 2006;20:178-3.CrossRef PubMed
  24.Vuori ML. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma: long-term results. Acta Ophthalmol. 2010;88:33-.CrossRef PubMed
  25.Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol.
• 作者单位：Daniel B. Moore (1)
  Sandra Stinnett (1)
  Glenn J. Jaffe (1)
  Sanjay Asrani (1)
  
  1. Duke University Eye Center, Durham, NC, USA
  
• 刊物主题：Internal Medicine; Ophthalmology;
• 出版者：Springer Healthcare
• ISSN：2193-6528

文摘

Introduction The purpose of this study was to determine whether the outcomes following placement of a fluocinolone acetonide implant (Retisert?; Bausch & Lomb, Inc.) combined with an Ahmed?glaucoma valve (New World Medical, Inc.) in eyes with uveitic glaucoma (UG Retisert) were different when compared to an Ahmed valve alone in eyes with uveitic glaucoma or primary open angle glaucoma (UG non-Retisert and POAG, respectively).